Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Investing.com -- Morgan Stanley expects the FDA to approve Gilead Sciences (NASDAQ: GILD )' Lenacapavir (LEN) for HIV ...
Three bovine veterinarians had undetected H5N1 avian influenza infections despite no apparent contact with infected cows, suggesting that there may be U.S. states with unidentified positive cases of ...
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
A groundbreaking injectable designed to curb the global spread of HIV is now at risk of being delayed due to Donald Trump's ...
Gilead Sciences has announced that the US Food and Drug Administration (FDA) has accepted its New Drug Application ...
This was the stock's third consecutive day of gains.
Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...
GlobalData on MSN6d
Gilead’s lenacapavir moves closer to FDA approval for HIV PrEP useLenacapavir is already approved under the name Sunlenca as an HIV treatment for patients resistant to other medication ...
The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV ...
Learn more about whether Gilead Sciences, Inc. or Insmed Incorporated is a better investment based on AAII's A+ Investor ...
The Marion Star on MSN7h
Wrestling roundup: Elgin adds to its trophy haul, wins D-III team title at sectionalsWrestling sectionals were held over the weekend and Marion-area competitors earned berths into the upcoming district ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback